home / stock / wxxwy / wxxwy news

WXXWY News and Press, Wuxi Biologics Cayman Inc ADR From 02/27/19

Stock Information
Company Name: Wuxi Biologics Cayman Inc ADR
Stock Symbol: WXXWY
Market: OTC
Menu
WXXWY WXXWY Quote WXXWY Short WXXWY News WXXWY Articles WXXWY Message Board
Get WXXWY Alerts

News, Short Squeeze, Breakout and More Instantly...
WXXWY - WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA

- The second product successfully receiving Breakthrough Therapy Designation that WuXi Biologics has enabled its partner to develop SHANGHAI , Feb. 28, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (Stock code: 2269.HK), a leading global open-access biologics technology...
WXXWY - ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million

SHANGHAI and SEOUL , Feb. 26, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and ABL Bio Corporation ("ABL Bio") (29...

WXXWY - EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo (TM) at WuXi Biologics

WuXi Biologics completed EMA GMP Inspection, the first biologics company in China SHANGHAI , Feb. 19, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics disco...

WXXWY - EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo(TM) at WuXi Biologics

SHANGHAI , Feb. 19, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced that the European Medicines Agency (EMA)...
WXXWY - WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

SHANGHAI and CRANBURY, N.J. , Feb. 12, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Amicus Therapeutics ("Amicus...

Previous 10 Next 10